CliffBio
small molecule

CETIRIZINE HYDROCHLORIDE ALLERGY

CETIRIZINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameCETIRIZINE HYDROCHLORIDE ALLERGY
Active ingredientCETIRIZINE HYDROCHLORIDE
Strength5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2013
Marketing statusDISCN

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CETIRIZINE HYDROCHLORIDE ALLERGY patent cliff — loss of exclusivity — | CliffBio